Literature DB >> 31862470

The innate immune response as a mediator of osteoarthritis pain.

R J Miller1, A-M Malfait2, R E Miller3.   

Abstract

In this narrative review, we discuss the emerging role of innate immunity in osteoarthritis (OA) joint pain. First, we give a brief description of the pain pathway in the context of OA. Then we consider how neuro-immune signaling pathways may promote OA pain. First, activation of neuronal Pattern Recognition Receptors by mediators released in a damaged joint can result in direct excitation of nociceptors, as well as in production of chemokines and cytokines. Secondly, indirect neuro-immune signaling may occur when innate immune cells produce algogenic factors, including chemokines and cytokines, that act on the pain pathway. Neuro-immune crosstalk occurs at different levels of the pathway, starting in the joint but also in the innervating dorsal root ganglia and in the dorsal horn. Synovitis is characterized by recruitment of immune cells, including macrophages, mast cells, and CD4+ lymphocytes, which may contribute to nociceptor sensitization and OA pain through production of algogenic factors that amplify the activation of sensory neurons. We discuss examples where this scenario has been suggested by findings in human OA and in animal models. Overall, increasing evidence suggests that innate immune pathways play an initiating as well as facilitating role in pain, but information on how these pathways operate in OA remains limited. Since these innate pathways are eminently targetable, future studies in this area may provide fruitful leads towards a better management of symptomatic OA.
Copyright © 2019 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Innate immunity; Neuroinflammation; Osteoarthritis; Pain; Sensitization; Toll-like receptors

Mesh:

Substances:

Year:  2019        PMID: 31862470      PMCID: PMC6951330          DOI: 10.1016/j.joca.2019.11.006

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  104 in total

Review 1.  The chemokine system in innate immunity.

Authors:  Caroline L Sokol; Andrew D Luster
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-29       Impact factor: 10.005

2.  Contribution of synovial macrophages to rat advanced osteoarthritis pain resistant to cyclooxygenase inhibitors.

Authors:  Yusuke Sakurai; Masahide Fujita; Shiori Kawasaki; Takao Sanaki; Takeshi Yoshioka; Kenichi Higashino; Soichi Tofukuji; Sosuke Yoneda; Tatsuya Takahashi; Ken Koda; Toshiyuki Asaki; Minoru Hasegawa; Yasuhide Morioka
Journal:  Pain       Date:  2019-04       Impact factor: 6.961

3.  Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice.

Authors:  Robert E Sorge; Michael L LaCroix-Fralish; Alexander H Tuttle; Susana G Sotocinal; Jean-Sebastien Austin; Jennifer Ritchie; Mona Lisa Chanda; Allyson C Graham; Lucas Topham; Simon Beggs; Michael W Salter; Jeffrey S Mogil
Journal:  J Neurosci       Date:  2011-10-26       Impact factor: 6.167

4.  Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis.

Authors:  L Longobardi; J D Temple; L Tagliafierro; H Willcockson; A Esposito; N D'Onofrio; E Stein; T Li; T J Myers; H Ozkan; M L Balestrieri; V Ulici; R F Loeser; A Spagnoli
Journal:  Osteoarthritis Cartilage       Date:  2016-11-14       Impact factor: 6.576

5.  An aggrecan fragment drives osteoarthritis pain through Toll-like receptor 2.

Authors:  Rachel E Miller; Shingo Ishihara; Phuong B Tran; Suzanne B Golub; Karena Last; Richard J Miller; Amanda J Fosang; Anne-Marie Malfait
Journal:  JCI Insight       Date:  2018-03-22

6.  Mast cells synthesize, store, and release nerve growth factor.

Authors:  A Leon; A Buriani; R Dal Toso; M Fabris; S Romanello; L Aloe; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions.

Authors:  Gail M Verge; Erin D Milligan; Steve F Maier; Linda R Watkins; Gregory S Naeve; Alan C Foster
Journal:  Eur J Neurosci       Date:  2004-09       Impact factor: 3.386

Review 8.  Emerging targets in neuroinflammation-driven chronic pain.

Authors:  Ru-Rong Ji; Zhen-Zhong Xu; Yong-Jing Gao
Journal:  Nat Rev Drug Discov       Date:  2014-06-20       Impact factor: 84.694

9.  CCL17 blockade as a therapy for osteoarthritis pain and disease.

Authors:  Ming-Chin Lee; Reem Saleh; Adrian Achuthan; Andrew J Fleetwood; Irmgard Förster; John A Hamilton; Andrew D Cook
Journal:  Arthritis Res Ther       Date:  2018-04-05       Impact factor: 5.156

Review 10.  Mechanisms of Osteoarthritis (OA) Pain.

Authors:  Terence W O'Neill; David T Felson
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096

View more
  20 in total

1.  Why we should study osteoarthritis pain in experimental models in both sexes.

Authors:  A M Malfait; R E Miller
Journal:  Osteoarthritis Cartilage       Date:  2020-01-09       Impact factor: 6.576

2.  Identification of Biomarkers Associated with Diagnosis of Osteoarthritis Patients Based on Bioinformatics and Machine Learning.

Authors:  Yihao Liang; Fangzheng Lin; Yunfei Huang
Journal:  J Immunol Res       Date:  2022-06-13       Impact factor: 4.493

Review 3.  The Genesis of Pain in Osteoarthritis: Inflammation as a Mediator of Osteoarthritis Pain.

Authors:  Matthew J Wood; Rachel E Miller; Anne-Marie Malfait
Journal:  Clin Geriatr Med       Date:  2022-05       Impact factor: 3.529

Review 4.  Basic Mechanisms of Pain in Osteoarthritis: Experimental Observations and New Perspectives.

Authors:  Anne-Marie Malfait; Rachel E Miller; Richard J Miller
Journal:  Rheum Dis Clin North Am       Date:  2021-05       Impact factor: 2.670

5.  Diabetes - osteoarthritis and joint pain.

Authors:  Annett Eitner; Britt Wildemann
Journal:  Bone Joint Res       Date:  2021-05       Impact factor: 5.853

6.  Multi-tissue epigenetic analysis of the osteoarthritis susceptibility locus mapping to the plectin gene PLEC.

Authors:  A K Sorial; I M J Hofer; M Tselepi; K Cheung; E Parker; D J Deehan; S J Rice; J Loughlin
Journal:  Osteoarthritis Cartilage       Date:  2020-06-21       Impact factor: 6.576

7.  Agnuside Alleviates Synovitis and Fibrosis in Knee Osteoarthritis through the Inhibition of HIF-1α and NLRP3 Inflammasome.

Authors:  Li Zhang; Xiaochen Li; Haosheng Zhang; Zhengquan Huang; Nongshan Zhang; Li Zhang; Runlin Xing; Peimin Wang
Journal:  Mediators Inflamm       Date:  2021-03-16       Impact factor: 4.711

8.  The role of intra-articular neuronal CCR2 receptors in knee joint pain associated with experimental osteoarthritis in mice.

Authors:  Shingo Ishihara; Alia M Obeidat; David L Wokosin; Dongjun Ren; Richard J Miller; Anne-Marie Malfait; Rachel E Miller
Journal:  Arthritis Res Ther       Date:  2021-04-07       Impact factor: 5.156

Review 9.  Peripheral mechanisms of arthritic pain: A proposal to leverage large animals for in vitro studies.

Authors:  Sampurna Chakrabarti; Minji Ai; Frances M D Henson; Ewan St John Smith
Journal:  Neurobiol Pain       Date:  2020-07-28

Review 10.  Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?

Authors:  Giorgia Della Rocca; Davide Gamba
Journal:  Animals (Basel)       Date:  2021-03-29       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.